On April 28, 2011, C&O announced that it has been authorized by Shionogi & Co., Ltd., a Japanese pharmaceutical company, to be the exclusive distributor of Flumarin®, an antibiotic of oxacephalosporins for injection, in China.

Flumarin® (flomoxef sodium for injection) is a broad-spectrum, next-generation oxycephalosporin antibiotic that is effective against a wide range of bacteria, including Gram-positive, negative and anaerobic bacteria.